Stay updated on Pembrolizumab with Targeted Therapy Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab with Targeted Therapy Clinical Trial page.

Latest updates to the Pembrolizumab with Targeted Therapy Clinical Trial page
- CheckyesterdayNo Change Detected
- Check9 days agoNo Change Detected
- Check16 days agoNo Change Detected
- Check23 days agoChange Detected- Added a government operating status notice and a link to operating details, plus a new version tag (v3.2.0). - Removed references to older revision (v3.1.0) and two disease terms (Mucosa-associated lymphoma; B-cell chronic lymphocytic leukemia).SummaryDifference2%

- Check30 days agoChange DetectedTerminology updated from Malt lymphoma to Mucosa-associated lymphoma, with a minor version increment from v3.0.2 to v3.1.0.SummaryDifference0.1%

- Check45 days agoChange DetectedUpdated revision from v3.0.1 to v3.0.2; removed Back to Top link (minor UI change).SummaryDifference0.1%

- Check52 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. Additionally, a 'Back to Top' feature has been added for improved navigation.SummaryDifference0.1%

- Check59 days agoChange DetectedThe web page has added significant medical content related to various types of lymphomas and treatments, while removing several related topics and terms, indicating a shift in focus towards specific conditions and therapies.SummaryDifference4%

- Check66 days agoChange DetectedThere are no significant changes to the web page content.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab with Targeted Therapy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab with Targeted Therapy Clinical Trial page.